Related references
Note: Only part of the references are listed.Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica
C. Devine et al.
PARASITOLOGY (2011)
A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica
E. Toner et al.
PARASITOLOGY (2010)
Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole
C. Devine et al.
PARASITOLOGY (2010)
Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole
Catherine Devine et al.
PARASITOLOGY RESEARCH (2010)
Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica
Catherine Devine et al.
PARASITOLOGY RESEARCH (2010)
Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host
E. Toner et al.
VETERINARY PARASITOLOGY (2010)
Interference with P-glycoprotein improves ivermectin activity against adult resistant nematodes in sheep
A. Lifschitz et al.
VETERINARY PARASITOLOGY (2010)
In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors
Raewadee Wisedpanichkij et al.
ACTA TROPICA (2009)
Interaction of Macrocyclic Lactones with the Multidrug Transporters: The Bases of the Pharmacokinetics of Lipid-Like Drugs
A. Lespine et al.
CURRENT DRUG METABOLISM (2009)
Xenobiotic metabolizing enzymes and metabolism of anthelminthics in helminths
Viktor Cvilink et al.
DRUG METABOLISM REVIEWS (2009)
Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans
Catherine E. James et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2009)
Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model
J. F. O'Neill et al.
JOURNAL OF HELMINTHOLOGY (2009)
Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep
G. Virkel et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2009)
Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility
Shanta M. Messerli et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2009)
Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica
C. Devine et al.
PARASITOLOGY (2009)
A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica
E. Toner et al.
PARASITOLOGY (2009)
Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica
L. Halferty et al.
PARASITOLOGY (2009)
Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha
M. McConville et al.
PARASITOLOGY (2009)
P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus
D. J. Bartley et al.
PARASITOLOGY (2009)
Morphological response of triclabendazole-susceptible and triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax)
B. McKinstry et al.
PARASITOLOGY RESEARCH (2009)
An update on P-glycoprotein and drug resistance in Schistosoma mansoni
Catherine E. James et al.
TRENDS IN PARASITOLOGY (2009)
Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica
L. Halferty et al.
VETERINARY PARASITOLOGY (2009)
Inhibition and induction of human cytochrome P450 enzymes: current status
Olavi Pelkonen et al.
ARCHIVES OF TOXICOLOGY (2008)
ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics
Anne Lespine et al.
TRENDS IN PARASITOLOGY (2008)
Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha
A. McConville et al.
VETERINARY PARASITOLOGY (2008)
Ketoconazole increases the plasma levels of ivermectin in sheep
Michel Alvinerie et al.
VETERINARY PARASITOLOGY (2008)
Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax)
B. McKinstry et al.
PARASITOLOGY RESEARCH (2007)
Fasciola hepatica:: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke
M. Meaney et al.
PARASITOLOGY RESEARCH (2007)
Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha
M. McConville et al.
PARASITOLOGY RESEARCH (2007)
ABC transporters and beta-tubulin in macrocyclic lactone resistance: prospects for marker development
R. K. Prichard et al.
PARASITOLOGY (2007)
Adult triclabendazole-resistant Fasciola hepatica:: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha
M. McConville et al.
PARASITOLOGY (2006)
Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep
G Virkel et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2006)
Drug transport mechanisms in helminth parasites: Passive diffusion of benzimidazole anthelmintics
L. Mottier et al.
EXPERIMENTAL PARASITOLOGY (2006)
Changes to oxfendazole chiral kinetics and anthelmintic efficacy induced by piperonyl butoxide in horses
SFS Bruni et al.
EQUINE VETERINARY JOURNAL (2005)
Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes
LI Alvarez et al.
PARASITOLOGY (2005)
Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica
M Meaney et al.
PARASITOLOGY RESEARCH (2005)
In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats
M Kageyama et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey
KW Ward et al.
DRUG METABOLISM AND DISPOSITION (2004)
The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica
MW Robinson et al.
PARASITOLOGY RESEARCH (2004)
Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon
M Meaney et al.
PARASITOLOGY RESEARCH (2004)
Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica
L Mottier et al.
XENOBIOTICA (2004)
Drug resistance in veterinary helminths
AJ Wolstenholme et al.
TRENDS IN PARASITOLOGY (2004)
P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance
D Kerboeuf et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin
J Dupuy et al.
VETERINARY PARASITOLOGY (2003)
Fasciola hepatica:: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen')
JF Buchanan et al.
PARASITOLOGY (2003)
Inhibition of cytochromes P450 by antifungal imidazole derivatives
WJ Zhang et al.
DRUG METABOLISM AND DISPOSITION (2002)
Interaction of common azole antifungals with P glycoprotein
EJ Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
